Get started
Author

Jens Lichte

Observed names: J. Lichte, Lichte, Jens
OpenAlex ID: A5023733355
GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy
2024 · Daniel Terheyden-Keighley, Melanie Hühne, et al. · Stem Cells Translational Medicine · 22
Off-the-Shelf GMP-Compliant iPS Cells for Application in Cell Therapy
2025 · B. Hiller, C. Träger, et al. · Cytotherapy · 1
Validated GMP banking of a new set of genomically stable induced pluripotent stem cell lines using single-cell passaging
2026 · Björn Hiller, Francois Hafezi, et al. · Cytotherapy
PDF
Data from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Figure from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
PDF
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Figure from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Data from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
2023 · Jessica M. Salmon, Izabela Todorovski, et al.
Characterization of the function of murine guanylate-binding protein 9 in the context of bacterial and parasitic infections
2019 · Jens Lichte, Daniel Degrandi, et al. · The Journal of Immunology
Works count: 26
Citation count: 23
H-index: 1
I10-index: 1
Year
Topic
Type